Turner JD, et al. - Experts evaluated a single-injection adductor canal block (SACB) with adjuvants to continuous adductor canal blockade (CACB). They presumed that the 2 groups would have equivalent analgesia at 30 hours post-neural blockade. For up to 36-hours following block placement, a SACB provided equivalent analgesia compared to a CACB for patients undergoing TKA, though a CACB was favoured at 42-hours and beyond. Findings suggested equivalent all numeric rating scale (NRS) pain scores until 42-hours (rest) and 48-hours (rest and movement) with the CACB group having lower pain scores. No statistical difference was seen in other secondary outcomes.